Causal effect of fasting serum glucose on atherosclerotic cardiovascular disease: a multivariable Mendelian randomization
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES Observational studies have reported that diabetes is a risk factor that increases the risk of atherosclerotic cardiovascular disease (ASCVD). However, the causal relationship remains a matter of debate. This study aimed to analyze the relationship between fasting serum glucose (FSG) and ASCVD. METHODS This study used data from the Korean Cancer Prevention Study-II (KCPS-II) Biobank, consisting of 159,844 people recruited with consent from 18 health examination centers from 2004 to 2013. Outcomes were confirmed based on diagnoses on hospital discharge summaries from National Health Insurance System. We used linear and non-linear Mendelian randomization (MR) methods. The outcome data were obtained from KCPS-II, and the exposure data were derived from the Korean Genome Epidemiology Study. RESULTS First, a prospective cohort study estimated that for each 10 mg/dL increase in FSG level, the risk of ASCVD increased by 5% (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.04 to 1.06). Second, the 2-sample MR study showed that every 10 mg/dL increase in FSG influenced the risk of ASCVD (odds ratio [OR], 1.11; 95% CI, 1.04 to 1.18). Third, the multivariable MR study showed that the OR per 10 mg/dL increase in FSG on ASCVD was 1.14 (p<0.001). Similar results were found for a 10 mg/dL increase in FSG and ischemic heart disease (IHD), but a significant relationship with stroke was not found. When performing non-linear MR, a linear relationship was observed between fasting blood sugar and ASCVD, including IHD and stroke. CONCLUSIONS FSG showed a linear and causal association with IHD, but not with stroke.
Abstract
OBJECTIVES Observational studies have reported that diabetes is a risk factor that increases the risk of atherosclerotic cardiovascular disease (ASCVD). However, the causal relationship remains a matter of debate. This study aimed to analyze the relationship between fasting serum glucose (FSG) and ASCVD. METHODS This study used data from the Korean Cancer Prevention Study-II (KCPS-II) Biobank, consisting of 159,844 people recruited with consent from 18 health examination centers from 2004 to 2013. Outcomes were confirmed based on diagnoses on hospital discharge summaries from National Health Insurance System. We used linear and non-linear Mendelian randomization (MR) methods. The outcome data were obtained from KCPS-II, and the exposure data were derived from the Korean Genome Epidemiology Study. RESULTS First, a prospective cohort study estimated that for each 10 mg/dL increase in FSG level, the risk of ASCVD increased by 5% (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.04 to 1.06). Second, the 2-sample MR study showed that every 10 mg/dL increase in FSG influenced the risk of ASCVD (odds ratio [OR], 1.11; 95% CI, 1.04 to 1.18). Third, the multivariable MR study showed that the OR per 10 mg/dL increase in FSG on ASCVD was 1.14 (p<0.001). Similar results were found for a 10 mg/dL increase in FSG and ischemic heart disease (IHD), but a significant relationship with stroke was not found. When performing non-linear MR, a linear relationship was observed between fasting blood sugar and ASCVD, including IHD and stroke. CONCLUSIONS FSG showed a linear and causal association with IHD, but not with stroke.
참고문헌 (38)
- Abbott RD, "Diabetes and the risk of stroke. The Honolulu Heart Program", JAMA, 257, pp.949~952 (1987)[DOI]
- Coutinho M, "The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years", Diabetes Care, 22, pp.233~240 (1999)[DOI]
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, "Report of the expert committee on the diagnosis and classification of diabetes mellitus", Diabetes Care, 26(Suppl 1), pp.S5~S20 (2003)[DOI]
- Spiller W, "Precision medicine and cardiovascular health : insights from Mendelian randomization analyses", Korean Circ J, 50, pp.91~111 (2020)[DOI]
- Lee SH, "Two-sample Mendelian randomization study of lipid levels and ischemic heart disease", Korean Circ J, 50, pp.940~948 (2020)[DOI]
- Gong Q, "Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance : 30-year results of the Da Qing Diabetes Prevention Outcome Study", Lancet Diabetes Endocrinol, 7, pp.452~461 (2019)[DOI]
- Jee YH, "Cohort profile : the Korean Cancer Prevention Study-II(KCPS-II)biobank", Int J Epidemiol, 47, pp.385~ (2018)[DOI]
- Jee SH, "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293, pp.194~202 (2005)[DOI]
- Kimm H, "Validity of the diagnosis of acute myocardial infarction in Korean National Medical Health Insurance claims data : the Korean Heart Study(1)", Korean Circ J, 42, pp.10~15 (2012)[DOI]
- Kim HY, "Validity of the diagnosis of acute myocardial infarction in Korean National Medical Health Insurance claims data: the Korean Heart Study", pp.2013
- Park JK, "The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims", Korean J Prev Med, 33, pp.76~82 (2000)
- Kim Y, "Cohort profile : the Korean genome and epidemiology study(KoGES)consortium", Int J Epidemiol, 46, pp.e20~ (2017)[DOI]
- Burgess S, "Guidelines for performing Mendelian randomization investigations : update for summer 2023", Wellcome Open Res, 4, pp.186~ (2023)[DOI]
- Burgess S, "Combining information on multiple instrumental variables in Mendelian randomization : comparison of allele score and summarized data methods", Stat Med, 35, pp.1880~1906 (2016)[DOI]
- Bowden J, "Mendelian randomization with invalid instruments : effect estimation and bias detection through Egger regression", Int J Epidemiol, 44, pp.512~525 (2015)[DOI]
- Bowden J, "Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator", Genet Epidemiol, 40, pp.304~314 (2016)[DOI]
- Burgess S, "Mendelian randomization analysis with multiple genetic variants using summarized data", Genet Epidemiol, 37, pp.658~665 (2013)[DOI]
- Oldroyd JC, "Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance", Diabetes Res Clin Pract, 72, pp.117~127 (2006)[DOI]
- Mannucci E, "Is glucose control important for prevention of cardiovascular disease in diabetes?", Diabetes Care, 36(Suppl 2), pp.S259~S263 (2013)[DOI]
- Panzer C, "Association of fasting plasma glucose with heart rate recovery in healthy adults : a population-based study", Diabetes, 51, pp.803~807 (2002)[DOI]
- Holman RR, "10-year follow-up of intensive glucose control in type 2 diabetes", N Engl J Med, 359, pp.1577~1589 (2008)[DOI]
- Gerstein HC, "Effects of intensive glycaemic control on ischaemic heart disease : analysis of data from the randomised, controlled ACCORD trial", Lancet, 384, pp.1936~1941 (2014)[DOI]
- Turnbull FM, "Intensive glucose control and macrovascular outcomes in type 2 diabetes", Diabetologia, 52, pp.2288~2298 (2009)[DOI]
- Park C, "Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases", Diabetes Care, 36, pp.1988~1993 (2013)[DOI]
- Abdul-Ghani MA, "Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose", Diabetes Care, 29, pp.1130~1139 (2006)[DOI]
- Ginsberg HN, "Insulin resistance and cardiovascular disease", J Clin Invest, 106, pp.453~458 (2000)[DOI]
- Laakso M, "Hyperglycemia and cardiovascular disease in type 2 diabetes", Diabetes, 48, pp.937~942 (1999)[DOI]
- Wojcik M, "Dietary sugar, salt and fat in human health", pp.305~323 (2020), Academic Press
- Nordestgaard BG, "Triglycerides and cardiovascular disease", Lancet, 384, pp.626~635 (2014)[DOI]
- Dhalla NS, "Role of oxidative stress in cardiovascular diseases", J Hypertens, 18, pp.655~673 (2000)[DOI]
- Cai H, "Endothelial dysfunction in cardiovascular diseases : the role of oxidant stress", Circ Res, 87, pp.840~844 (2000)[DOI]
- Bordia A, "Effect of ginger(Zingiber officinale Rosc. )and fenugreek(Trigonella foenumgraecum L. )on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease", Prostaglandins Leukot Essent Fatty Acids, 56, pp.379~384 (1997)[DOI]
- Adachi H, "Is insulin resistance or diabetes mellitus associated with stroke? An 18-year follow-up study", Diabetes Res Clin Pract, 51, pp.215~223 (2001)[DOI]
- De Vriese AS, "Endothelial dysfunction in diabetes", Br J Pharmacol, 130, pp.963~974 (2000)[DOI]
- Marfella R, "The effect of acute hyperglycaemia on QTc duration in healthy man", Diabetologia, 43, pp.571~575 (2000)[DOI]
- Smith GD, "‘Mendelian randomization’ : can genetic epidemiology contribute to understanding environmental determinants of disease?", Int J Epidemiol, 32, pp.1~22 (2003)[DOI]
- Lawlor DA, "Mendelian randomization : using genes as instruments for making causal inferences in epidemiology", Stat Med, 27, pp.1133~1163 (2008)[DOI]
- Emerging Risk Factors Collaboration, "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies", Lancet, 375, pp.2215~2222 (2010)[DOI]